Related Experiment Video
Updated: Mar 23, 2026
Analysis of Human Natural Killer Cell Metabolism
Published on: June 22, 2020
Ionomycin Treatment Renders NK Cells Hyporesponsive
Gema Romera-Cárdenas1, L Michael Thomas2, Sheila Lopez-Cobo1
1Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Científicas, CNB-CSIC, Madrid, Spain.
Abstract:
Natural killer cells are cytotoxic lymphocytes important in immune responses to cancer and multiple pathogens. However, chronic activation of NK cells can induce a hyporesponsive state. The molecular basis of the mechanisms underlying the generation and maintenance of this hyporesponsive condition are unknown, thus an easy and reproducible mechanism able to induce hyporesponsiveness on human NK cells would be very useful to gain understanding of this process. Human NK cells treated with ionomycin lose their ability to degranulate and secrete IFN-γ in response to a variety of stimuli, but IL-2 stimulation can compensate these defects. Apart from reductions in the expression of CD11a/CD18, no great changes were observed in the activating and inhibitory receptors expressed by these NK cells, however their transcriptional signature is different to that described for other hyporesponsive lymphocytes.
Insights
Researchers found that treating human natural killer (NK) cells with ionomycin induces hyporesponsiveness, a state where they lose function. Interleukin-2 (IL-2) can reverse this NK cell defect.
Area of Science:
- Immunology
- Cellular Biology
- Cancer Research
Background:
- Natural killer (NK) cells are crucial cytotoxic lymphocytes for immune defense against cancer and pathogens.
- Chronic activation can lead to NK cell hyporesponsiveness, impairing immune function.
- The molecular mechanisms driving NK cell hyporesponsiveness remain largely unknown.
Purpose of the Study:
- To establish a reproducible method for inducing hyporesponsiveness in human NK cells.
- To investigate the molecular changes associated with ionomycin-induced NK cell hyporesponsiveness.
- To explore potential therapeutic interventions for restoring NK cell function.
Main Methods:
- Human NK cells were treated with ionomycin to induce hyporesponsiveness.
- Functional assays measured degranulation and interferon-gamma (IFN-γ) secretion.
- Flow cytometry assessed the expression of activating and inhibitory receptors.
- Transcriptional profiling was performed to identify molecular alterations.
Main Results:
- Ionomycin treatment significantly reduced NK cell degranulation and IFN-γ secretion.
- Interleukin-2 (IL-2) stimulation partially restored the impaired functions of hyporesponsive NK cells.
- While CD11a/CD18 expression decreased, major changes in other NK cell receptors were not observed.
- Transcriptional analysis revealed a unique signature distinct from other hyporesponsive lymphocytes.
Conclusions:
- Ionomycin provides a valuable tool for studying NK cell hyporesponsiveness in vitro.
- Understanding the transcriptional changes in hyporesponsive NK cells is key to deciphering their dysfunction.
- IL-2 holds potential for reversing NK cell hyporesponsiveness and restoring immune function.
Related Concept Videos
01:27Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists